Editorials and Opinions

Should drug prices differ by indication?

Nearly 90 percent of newly launched medicines are available in the United States.

A Comparison of Value-Based and Net Prices Using Institute for Clinical and Economic Review Reports

What Is a Prescription Drug Subscription Model?

What are the availability and quality of cost-effectiveness studies on drugs with the greatest Medicare Part D spending?

Journey of Generic Imatinib - A Case Study in Oncology Drug Pricing

Recommendations on value assessment and funding processes in rare diseases.

Europe is the second largest biopharmaceutical market in the world, with the 28 European Union (EU) countries accounting for $211 billion (18 per cent) of the total $1,133 billion market in 2018.

What do cancer drugs improve?

The use of ‘added benefit’ to determine the price of new anti-cancer drugs in France, 2004-2017.

How much does it costs to develop a new drug -- start to finish?

Development of therapeutic antibodies for the treatment of diseases.

Value-based health care in four different health care systems.

A global distribution of biopharmaceutical companies by Research & Development spend.

How price indices are used to compare prescription drug prices between countries.